TURKISH JOURNAL OF PEDIATRICS, cilt.46, sa.4, ss.322-328, 2004 (SCI-Expanded)
Over the past 20 years, orally administered biphosphonates have been used extensively in the management of a number of common skeletal disorders of different etiology. Recently, in clinical practice, in a number of cases in whom oral therapy is insufficient or contraindicated, intravenous administration of pamidronate presents an alternative therapeutic option.